As a result, we observed stronger activation of CD8+ T cells and a more immunostimulatory tumor microenvironment, including elevated IFN-γ secretion and increased infiltration of tumor-infiltrating lymphocytes. The gene discussed is IFNG; the disease is neoplasm.